Cancer cells survive by hiding from the immune system's surveillance. A KAIST research team has developed a new anticancer platform that makes cancer cells send out their own danger signals—prompting immune cells to attack—while simultaneously delivering gene therapy. The approach is expected to offer a new treatment strategy that combines cancer immunotherapy and gene therapy in a single nanoparticle.
🛡️
Just a quick checkWe’re checking your connection to prevent automated abuse
| # | Наименование новости | Тональность | Информативность | Дата публикации |
|---|---|---|---|---|
| 1 | Acid-resistant nanocage shows promise for targeted gastric cancer therapy | 0 | 9.81 | 20-07-2026 |
| 2 | Combined nanoparticle and internal laser method could make cancer therapy less invasive | 0 | 7.19 | 22-07-2026 |
| 3 | Biodegradable implant can deliver targeted cancer immunotherapy while protecting healthy tissue | 0 | 9.45 | 27-07-2026 |
| 4 | Нижегородские ученые разработали комплексы для одновременной терапии и диагностики рака | 0 | 0 | 20-12-2018 |
| 5 | В США создали наночастицы, заставляющие иммунитет атаковать рак яичников | 0 | 0 | 31-10-2025 |
| 6 | Ученые создали оружие против неизлечимого рака | 7 | 8 | 15-07-2026 |
| 7 | Giving antibodies 'eyes' may help target hidden KRAS mutations in cancer cells | 0 | 8.03 | 24-07-2026 |
| 8 | Researchers discover novel SRV2 envelope protein for efficient CAR immune cell production | 5 | 7 | 01-07-2026 |
| 9 | Nanopores can activate human T cells without biochemical signals | 0 | 8.06 | 23-07-2026 |
| 10 | Chemists develop a molecular platform for the selective control of oxygen reaction pathways | 0 | 8.66 | 22-07-2026 |